Year |
Citation |
Score |
2022 |
Quaranta V, Linkous A. Organoids as a Systems Platform for SCLC Brain Metastasis. Frontiers in Oncology. 12: 881989. PMID 35574308 DOI: 10.3389/fonc.2022.881989 |
0.304 |
|
2020 |
Pine AR, Cirigliano SM, Nicholson JG, Hu Y, Linkous A, Miyaguchi K, Edwards L, Singhania R, Schwartz TH, Ramakrishna R, Pisapia DJ, Snuderl M, Elemento O, Fine HA. Tumor microenvironment is critical for the maintenance of cellular states found in primary glioblastomas. Cancer Discovery. PMID 32253265 DOI: 10.1158/2159-8290.Cd-20-0057 |
0.422 |
|
2019 |
Linkous A, Balamatsias D, Snuderl M, Edwards L, Miyaguchi K, Milner T, Reich B, Cohen-Gould L, Storaska A, Nakayama Y, Schenkein E, Singhania R, Cirigliano S, Magdeldin T, Lin Y, et al. Modeling Patient-Derived Glioblastoma with Cerebral Organoids. Cell Reports. 26: 3203-3211.e5. PMID 30893594 DOI: 10.1016/J.Celrep.2019.02.063 |
0.375 |
|
2017 |
Baysan M, Woolard K, Cam MC, Zhang W, Song H, Kotliarova S, Balamatsias D, Linkous A, Ahn S, Walling J, Belova GI, Fine HA. Detailed Longitudinal Sampling of Glioma Stem Cells In Situ Reveals Chr7 Gain and Chr10 Loss As Repeated Events in Primary Tumor Formation and Recurrence. International Journal of Cancer. PMID 28710771 DOI: 10.1002/Ijc.30887 |
0.406 |
|
2017 |
Riddick G, Kotliarova S, Rodriguez V, Kim HS, Linkous A, Storaska AJ, Ahn S, Walling J, Belova G, Fine HA. A Core Regulatory Circuit in Glioblastoma Stem Cells Links MAPK Activation to a Transcriptional Program of Neural Stem Cell Identity. Scientific Reports. 7: 43605. PMID 28256619 DOI: 10.1038/Srep43605 |
0.312 |
|
2013 |
Bhave SR, Dadey DY, Karvas RM, Ferraro DJ, Kotipatruni RP, Jaboin JJ, Hallahan AN, Dewees TA, Linkous AG, Hallahan DE, Thotala D. Autotaxin Inhibition with PF-8380 Enhances the Radiosensitivity of Human and Murine Glioblastoma Cell Lines. Frontiers in Oncology. 3: 236. PMID 24062988 DOI: 10.3389/Fonc.2013.00236 |
0.571 |
|
2012 |
Linkous AG, Yazlovitskaya EM. Novel radiosensitizing anticancer therapeutics. Anticancer Research. 32: 2487-99. PMID 22753705 |
0.432 |
|
2012 |
Linkous AG, Yazlovitskaya EM. Novel therapeutic approaches for targeting tumor angiogenesis. Anticancer Research. 32: 1-12. PMID 22213282 |
0.347 |
|
2011 |
Schleicher SM, Thotala DK, Linkous AG, Hu R, Leahy KM, Yazlovitskaya EM, Hallahan DE. Autotaxin and LPA receptors represent potential molecular targets for the radiosensitization of murine glioma through effects on tumor vasculature. Plos One. 6: e22182. PMID 21799791 DOI: 10.1371/Journal.Pone.0022182 |
0.591 |
|
2011 |
Linkous AG, Yazlovitskaya EM. Angiogenesis in glioblastoma multiforme: navigating the maze. Anti-Cancer Agents in Medicinal Chemistry. 11: 712-8. PMID 21707499 DOI: 10.2174/187152011797378643 |
0.43 |
|
2011 |
Schulte RR, Linkous AG, Hallahan DE, Yazlovitskaya EM. Cytosolic phospholipase A2 as a molecular target for the radiosensitization of ovarian cancer. Cancer Letters. 304: 137-43. PMID 21397389 DOI: 10.1016/J.Canlet.2011.02.015 |
0.64 |
|
2011 |
Linkous A, Yazlovitskaya E. PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) Atlas of Genetics and Cytogenetics in Oncology and Haematology. DOI: 10.4267/2042/44862 |
0.332 |
|
2010 |
Linkous AG, Yazlovitskaya EM, Hallahan DE. Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis. Journal of the National Cancer Institute. 102: 1398-412. PMID 20729478 DOI: 10.1093/Jnci/Djq290 |
0.591 |
|
2010 |
Linkous A, Yazlovitskaya E. Cytosolic phospholipase A2 as a mediator of disease pathogenesis Cellular Microbiology. 12: 1369-1377. PMID 20642808 DOI: 10.1111/J.1462-5822.2010.01505.X |
0.384 |
|
2009 |
Linkous A, Geng L, Lyshchik A, Hallahan DE, Yazlovitskaya EM. Cytosolic phospholipase A2: targeting cancer through the tumor vasculature. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 1635-44. PMID 19240173 DOI: 10.1158/1078-0432.Ccr-08-1905 |
0.656 |
|
2008 |
Yazlovitskaya EM, Linkous AG, Thotala DK, Cuneo KC, Hallahan DE. Cytosolic phospholipase A2 regulates viability of irradiated vascular endothelium. Cell Death and Differentiation. 15: 1641-53. PMID 18566601 DOI: 10.1038/Cdd.2008.93 |
0.542 |
|
2008 |
Linkous A, Geng L, Hallahan D, Yazlovitskaya E. Cytosolic Phospholipase a2 (cpla2): Targeting Cancer Through the Ablation of Tumor Vasculature International Journal of Radiation Oncology*Biology*Physics. 72: S64. DOI: 10.1016/J.Ijrobp.2008.06.909 |
0.607 |
|
2007 |
Linkous A, Cuneo K, Hallahan D, Yazlovitskaya E. Cytosolic Phospholipase A2-Dependent Signaling Protects Normal Cells From Radiation-Induced Cytotoxicity International Journal of Radiation Oncology*Biology*Physics. 69: S127. DOI: 10.1016/J.Ijrobp.2007.07.236 |
0.576 |
|
2006 |
Yazlovitskaya E, Cuneo K, Linkous A, Hallahan D. 2602 International Journal of Radiation Oncology*Biology*Physics. 66: S544-S545. DOI: 10.1016/J.Ijrobp.2006.07.1016 |
0.446 |
|
Show low-probability matches. |